5-(2-苯基乙-1-炔基)-2-呋喃甲酸 | 130423-83-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 呋喃
• 中文名称: 5-(2-苯基乙-1-炔基)-2-呋喃甲酸
• 中文别名: 5-(2-苯基乙炔)呋喃-2-羧酸；5-(苯基乙基)呋喃-2-羧酸；5-[1-(2-苯基)乙炔基]-2-呋喃甲酸
• 英文名称: 5-(phenylethynyl)furan-2-carboxylic acid
• 英文别名: 5-(2-phenylethynyl)furan-2-carboxylic acid
• CAS: 130423-83-5
• 化学式: C₁₃H₈O₃
• mdl: MFCD00541949
• 分子量: 212.205
• InChiKey: HFYACYZCOUYIFR-UHFFFAOYSA-N

物化性质

• 熔点：
  212 °C
• 沸点：
  411.0±30.0 °C(Predicted)
• 密度：
  1.33±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  50.4
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2932190090

SDS

Name:	5-(2-Phenyleth-1-ynyl)-2-furoic acid tech Material Safety Data Sheet
Synonym:
CAS:	130423-83-5

Section 1 - Chemical Product MSDS Name:5-(2-Phenyleth-1-ynyl)-2-furoic acid tech Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
130423-83-5	5-(2-Phenyleth-1-ynyl)-2-furoic acid		unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 130423-83-5: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 204 - 205 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C13H8O3
Molecular Weight: 212

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 130423-83-5 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
5-(2-Phenyleth-1-ynyl)-2-furoic acid - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 130423-83-5: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 130423-83-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 130423-83-5 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-(2-苯基乙-1-炔基)-2-呋喃甲酸 生成 5-(2-苯基-1-乙炔)-2-糠酸甲酯
  参考文献：
  名称：

  ZAVODNOV, V. S.;KULNEVICH, V. G.;ZINOVEV, V. D., XIMIYA GETEROTSIKL. SOED.,(1990) N, S. 453-456

  摘要：

  DOI：
• 作为产物：
  描述：

  5-(phenylethynyl)furan-2-carbaldehyde 生成 5-(2-苯基乙-1-炔基)-2-呋喃甲酸
  参考文献：
  名称：

  ZAVODNOV, V. S.;KULNEVICH, V. G.;ZINOVEV, V. D., XIMIYA GETEROTSIKL. SOED.,(1990) N, S. 453-456

  摘要：

  DOI：

文献信息

• [EN] SPIROPIPERIDINES FOR USE AS TRYPTASE INHIBITORS<br/>[FR] SPIROPIPÉRIDINES UTILISABLES EN TANT QU'INHIBITEURS DE LA TRYPTASE
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2009067202A1

  公开（公告）日：2009-05-28

  The present invention is directed to a compound of Formula (I): (I) or a form thereof, wherein X1, X2, X3, X4, R1, R2 and R3 are as defined herein, useful as tryptase inhibitors.

  本发明涉及一种化合物，其化学式为（I）：（I）或其形式，其中X1、X2、X3、X4、R1、R2和R3如本文所定义，可用作色氨酸蛋白酶抑制剂。
• Chemical compounds
  申请人：Astles C. Peter

  公开号：US20050228018A1

  公开（公告）日：2005-10-13

  Provided herein are novel and useful compounds having a tryptase inhibition activity, pharmaceutical compositions comprising such compounds, and methods treating subjects suffering from a condition, disease, or disorder that can be ameliorated by the administration of an inhibitor of tryptase, e.g., asthma and inflammatory diseases, to name only a few.

  本文提供了一些新颖和有用的化合物，具有抑制胰蛋白酶活性，包括这些化合物的药物组合物，以及治疗患有可通过给予胰蛋白酶抑制剂（例如哮喘和炎症性疾病等）治疗的疾病、病症或障碍的方法。
• Substituted N-aryl Heterocycles, Process For Their Preparation and Their Use As Medicaments
  申请人：Schwink Lothar

  公开号：US20070207991A1

  公开（公告）日：2007-09-06

  The invention relates to substituted N-aryl heterocycles and to the physiologically tolerated salts and physiologically functional derivatives thereof. Compounds of the formula I in which the radicals have the stated meanings the N-oxides and the physiologically tolerated salts thereof and process for the preparation thereof are described. The compounds are suitable for example as anorectic agents.

  该发明涉及取代的N-芳基杂环化合物及其生理耐受盐和生理功能衍生物。描述了公式I中化合物，其中基团具有所述的含义，以及其N-氧化物和生理耐受盐和其制备方法。这些化合物例如适用于作为抑制食欲的药物。
• SPIROPIPERIDINES FOR USE AS TRYPTASE INHIBITORS
  申请人：Costanzo Michael J.

  公开号：US20120165327A1

  公开（公告）日：2012-06-28

  The present invention is directed to a compound of Formula (I): or a form thereof, wherein X 1 , X 2 , X 3 , X 4 , R 1 , R 2 and R 3 are as defined herein, useful as tryptase inhibitors.

  本发明涉及一个公式(I)的化合物或其形式，其中X1，X2，X3，X4，R1，R2和R3如本文所定义，可用作组胺酶抑制剂。
• Spiropiperidines for use as tryptase inhibitors
  申请人：Costanzo Michael J.

  公开号：US20090163527A1

  公开（公告）日：2009-06-25

  The present invention is directed to a compound of Formula (I): or a form thereof, wherein X 1 , X 2 , X 3 , X 4 , R 1 , R 2 and R 3 are as defined herein, useful as tryptase inhibitors.

  本发明涉及一种化合物，其化学式为(I)或其形式，其中X1、X2、X3、X4、R1、R2和R3的定义如本文所述，用作胰蛋白酶抑制剂。